News and Announcements
International travel photographer Henry Do joins the Soar platform
- Published October 25, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- International photographer Henry Do has joined the Soar platform.
- The world’s first blockchain, mapping technology is offering investors and enthusiasts a 33% bonus on SKYM tokens purchased during the presale.
- Only 6 days remain until the Soar TGE presale closes
Soar TGE has announced that there are only 6 days until its pre-sale closing date.
This is now the last chance for investors and enthusiasts to secure a 33% bonus on purchases of Soar’s SKYM tokens if they sign up and buy during the presale period.
The company is excited to announce that International travel photographer, Henry Do, has joined the Soar platform.
Henry is famous for his aerial photography which offers a unique perspective of travel destinations.
Soar are hosting an AMA on the 25th October, at 4:30pm, you can submit questions here.
Soar’s favourite question will win the AMA giveaway.
The Soar platform is designed to offer the international community a decentralised marketplace for high quality drone footage, aerial maps and satellite imagery that connects customers with content creators in a secure, trustless and distributed community leveraging blockchain technology. You can view the public Test Net prototype at demo.soar.earth.
About Soar
Soar is a decentralised global platform for the distribution and monetisation of drone content. Initially, the Soar platform is designed to offer a democratised that connects customers with content creators in a secure, trustless and distributed community. However, this isn’t the end-game. Progressively, by aggregating the content collected from thousands of drone operators, Soar will in due course create a dynamic database for the world’s first super-map at an unprecedented level of detail. All connected using blockchain technology to connect and share data.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
